AAV Vector-Mediated Antibody Delivery (A-MAD) in the Central Nervous System
In the last four decades, monoclonal antibodies and their derivatives have emerged as a powerful class of therapeutics, largely due to their exquisite targeting specificity. Several clinical areas, most notably oncology and autoimmune disorders, have seen the successful introduction of monoclonal-ba...
Zapisane w:
| Główni autorzy: | , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Frontiers Media S.A.
2022-04-01
|
| Seria: | Frontiers in Neurology |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.frontiersin.org/articles/10.3389/fneur.2022.870799/full |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|